8 February 2021 - Deborah Wilkes
Premium
Sweden’s Karo Pharma is acquiring a portfolio of OTC brands – including the Flux fluoride rinse and Decubal skincare products – from Israel’s Teva for EUR84 million (USD102 million).
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.